InvestorsHub Logo
Followers 3
Posts 66
Boards Moderated 0
Alias Born 12/17/2020

Re: marjac post# 357656

Friday, 10/22/2021 7:03:48 PM

Friday, October 22, 2021 7:03:48 PM

Post# of 426069
Marjac, I disagree that the case has merit. For the case to have any merit, one has to get passed the sharp drop in the stock price after the court ruling. If it was so obvious, why wasn't the market more in tune with the legal proceedings when they were argued? One would also have to include Goldman Sachs and any other brokerage firm that was involved with the secondary offering which is full of disclosures and risks. Was Goldman and the others also at fault for helping perpetuate the fraud?The company has to disclose the risks, not predict or offer an opinion about what is going to happen. How does one reconcile "the increasingly high risks that the certain patents would be invalidated" when the Hikma CEO was quoted as saying "it was a longshot that was worth taking" after the verdict? How does one rightfully sue a company for letting litigation get in the way of a takeover that can never be publicly disclosed and maybe there were discussions. Every company could be liable for not selling themselves once an undefined problem manifests itself. How does one predict or discuss that companies are going to break the law and take your legally protected (loosely used here) market?

I am not a lawyer and these are my opinions. I have lost a lot of money here and I will take my lumps. I would be interested in hearing how you, or any other lawyer here would have made the appropriate disclosures to avoid a lawsuit. How does one quantify the risks of litigation and it's outcome?

I am not arguing with you and do not want to appear to be combative or in any way suggesting that you are wrong. I just don't see any merit here.

Thank you for all the work that you have done and trying to save the day. I did contribute to kitty to fund some of your legal work.

Sincerely.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News